type full_text History And Physical Findings 89 year old male NKDAÂ ADL I Home bound ambulant with WF, WC in community Non smoker . PAST MEDICAL HISTORY: 1. Hypertension 2. Hyperlipidaemia 3. Old CVA with good functional recovery, prev on aspirin last CT brain in Aug '07: recent infarcts in L external capsule and temporal lobe no previous TCD/ECD 4. Cardiac ulcer and hyperplastic polyp s/p polypectomy in 2001 presented with malaena and hemetemesis 5. Thiazide induced electrolyte imbalance in 2007 6. Atypical chest pain last MIBI in Sept '10: normal LVEF and coronary flow reserve 7. Vitamin B 12 deficiency noted during admission to cardiology in Sept '10 antiparietal cell Ab and anti IF positive on regular IM B 12 injectionÂ 8. L cataract s/p phaco and IOL (Jan 2015)Â 9. HaemorrhoidsÂ 10. Cataract s/p R phaco 11. IHD with ischemic CMP OOHVFC with inf STEMI 20/3/20 Coros 20/3/20 LM normal LAD calcified 75 diffuse ostial LAD and 75 mid LAD lesionÂ LCx minor disease RCA 100 RPDA occlusion s/p POBA of 100 RPDA occlusion 20/3/20 (stent not deployed in view of small RPDA) s/p staged PCI DES of LM LAD on 23/3/20 required IABP support in CCU TTE March 2020: EF 38 , multiple RWMA, PASP 49. IVC dilated and non compressible.Â initially on DAPT aspirin tica > then switched to plavix rivaroxaban in view of AF > OAC stopped due to extensive bruising TTE May 2020: LVEF 30 , mod MR, mod severe TR, low CI<1.2 12. Post MI AF with sinus pause CHADSVASC 6 started on apixaban/plavix initally then stopped due to extensive bruising s/p VVIR PPM inserted on 25/3/20 . CHRONIC MEDS: Calcium carb/vit D 1 tab OM Plavix 75 mg OM DAPT (aspirin plavix) till 23/03/2021 Aspirin EC 100 mg OMÂ Omeprazole 20 mg OM pre meal Neurobion 1 tab OM Bisoprolol 3.75 mg/1.25 mg BD Lisinopril 2.5 mg OM Hydralazine 25 mg TDS ISDN 10 mg BD (8 am, 2 pm) Lasix 40 mg OM and 40 mg 2 pm PRN for LL swelling Span K 600 mg OM Atorvastatin 40 mg ON . CURRENT PRESENTATION: 1. Hemoptysis this morning was coughing out phlegm when had 1 episode of blood clot in sputum no previous hemoptysis before a/w cough past 3 days no other ARI symptoms of sore throat, runny nose no fever no chest pain or palpitations no SOB no night sweats, recent LOA or LOW had TB in his 20 s, treated with 6 months of meds no exposure to COVID 19 cases/clusters no sick contact . 2. SOB OE and LL swelling Unable to quantify duration No orthopnea, sleeps on 1 pillow. Denies PND Used to be able to walk around house, but now is breathless on walking around house (unable to quantify) and housework No chest pain, compliant to medications no recent increased fluid intake . VITALS: Triage: T 36.5 BP 139/87 HR 59 RR 28 SpO2 99 RA GW: T 36.6 BP 151/84 HR 60 RR 24 SpO2 97 RA . ON EXAMINATION: alert and comfortable not toxic not in respi distress H S 1 S 2 PSM L bibasal creps A SNT Calves supple, mild pedal edema up to ankles . INITIAL INVESTIGATIONS: TW 6.13 Hb 14.4 Plt 179 Na 139 K 3.4 Cr 151 bicarb 25 Trop I 59.7 BNP 15,391 INR 1.19 aPTT 26.3 CXR: Left lower zone consolidation is noted. Please correlate clinically for infection. Bilateral small pleural effusions are seen, worse on the right. Right apical pleural thickening is noted. . PROGRESS IN ED: 40 mg IV lasix, IV augmentin, PO azithromycin . ISSUES AND PROGRESS: 1. ADHF with troponin leak, likely secondary to ventricular dyssynchrony from PPM Â TTE May 2020: LVEF 30 , mod MR, mod severe TR, low CI<1.2)m trop 52 < 59 initially given IV diuretics (old dose lasix 40 mg oralÂ BD PRN) on lisinopril, bisoprolol s/p PPM upgrade w/ selective left bundle pacing on 11/6/20 device check on 12/6/20 done covered w/ prophylactic IV vanco then PO cipro for PPM upgrade converted to PO lasix 40 mg BD on discharge . 2. CAP with small volume haemoptysis TW 6.13 CXR: Left lower zone consolidation is noted.Â Bilateral small pleural effusions are seen, worse on the right. Right apical pleural thickening is noted. Â 1 episode of hemoptysis during stay AFB smear TB molecular x 1 set ve (not pooled) completed 7 days augmentin 2 days azithromycin . 3. Post procedure AF/atrial flutter on 11/6/20 electrolytes replaced . 4. Stable CKD stage 3 Cr 167 (6/6) > 151 (11/6) > 144 (12/6) baseline 170 s . 5. COVID s ve Fulfills MOH screening criteria of pneumonia COVID swab taken 5/6/2020 1535 H ve . Patient was discharged stable on 13/6/20. . Medication changes: Stopped hydralazine 25 mg TDS and ISDN 10 mg BD (8 am, 2 pm) Converted bisoprolol dosing to 2.5 mg BD Increased lasix to 40 mg BD w/ span K 1 tab BD . Discharge plans: Post device implantation review clinic:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â TCU 10 to 14 days Arrhythmia NurseÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â TCU 4/52 to 6/52Â Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] Â Â Â Â Â Â Cancel Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] HF clinic 3/12, RP OA Outcome Followup Plan Post device implantation review clinic: TCU 10 to 14 days Arrhythmia Nurse TCU 4/52 to 6/52 Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] Cancel Dr [REDACTED] [REDACTED] [REDACTED][REDACTED] clinic 3/12, RP OA